| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.42B | $958.1M | $1.79B |
| YoY Revenue Growth % | +48.5% | -46.5% | — |
| Gross Profit | $1.06B | $606.9M | — |
| Gross Margin % | 74.8% | 63.3% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $600.4M | -$236.8M | $974.8M |
| Operating Margin % | 42.2% | -24.7% | 54.4% |
| Net Income (GAAP) | $428.0M | -$261.0M | $1.47B |
| EBITDA (Normalized) | — | — | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $803.2M | $650.0M | $723.2M |
| Capital Expenditures (CapEx) | — | — | — |
| Free Cash Flow (FCF) | $803.2M | $650.0M | $723.2M |
| FCF Margin % | 56.5% | 67.8% | 40.4% |
| Return on Invested Capital (ROIC %) | 18.1% | -7.8% | — |
| Cash & Short-Term Equivalents | $1.8M | $1.5M | — |
| Total Debt (Short + Long Term) | $788.2M | $702.9M | — |
| Total Stockholders' Equity | $1.83B | $1.71B | — |